Page URL: https://www.bionews.org.uk/page_92148

US company offers parents home testing for inheritable genetic diseases

1 February 2010
Appeared in BioNews 543

A company in the US is offering potential parents the chance to test whether their future offspring might develop serious health problems by selling them home genetic test kits. The company Counsyl allows customers to send a saliva sample via the post, which is used in conjunction with DNA chip technology to screen if the person is a carrier for a single genetic mutation known to cause a disease. If both parents carry the same mutation, there is a one in four chance that any child they conceive will develop the disease.

The test checks for diseases such as cystic fibrosis, Tay-Sachs or sickle cell anaemia. If the couple is found to be at risk of passing such traits onto their children, steps can be taken to prevent this, such as using genetic screening of embryos to which are implanted for IVF. The company stated that 35-40 per cent of couples tested were carriers for at least one condition, and in 0.6-0.8 per cent of the cases, both parents in the couple were found to be carriers for the same genetic mutation.

Genetic tests are already carried out by hospitals, but only for a few of the more common conditions, and they often cost a lot of money. Counsyl offers its test for over 100 diseases, and charges $698, much less than the old blood tests cost, according to The New York Times (NYT) newspaper.

Balaji Srinivasan, the company's chief technology officer, told the NYT: 'The goal is not to maximise revenue but to bring the benefits to humanity. Nothing is more relevant than making sure your child doesn't die from a preventable disease'.

Feelings about Counsyl are mixed, according to quotes obtained by the NYT. Elena Ashkinadze, a prenatal genetic counsellor at the Robert Wood Johnson Medical School in New Jersey, said: 'As a genetic counsellor, I've been waiting for this for a really long time'. But Michael S Watson, executive director of the American College of Medical Genetics, said that many mutations are silent, meaning there is no risk to offspring. Couples might be needlessly worried.

Other experts told the NYT that a rise in identification of carriers would overwhelm the use of genetic counsellors. Also, the test looks for only 100 diseases - there are thousands of genetic conditions identified so far, which will not be tested for.

SOURCES & REFERENCES
Firm Brings Gene Tests to Masses
The New York Times |  28 January 2010
Prevent Genetic Disease before Pregnancy with a DNA Test - Counsyl
Counsyl |  29 January 2010
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
7 September 2020 - by Sarah Norcross 
This week, the Progress Educational Trust – in partnership with the Scottish Government – will be exploring the role of traditional and expanded carrier screening in assessing the suitability of sperm and egg donors...
21 February 2011 - by Rosemary Paxman 
A new genetic test screening for almost 450 rare childhood genetic diseases could be available in the US this year, reports the Beyond Batten Disease Foundation (BBDF)....
17 January 2011 - by Victoria Kay 
A new genetic test could lead to the elimination of hundreds of inherited diseases, US scientists claim....
17 January 2011 - by Rosie Beauchamp 
A recent study suggests American consumers would be prepared to pay on average up to $600 for a predictive genetic test where no direct treatment is available....
15 February 2010 - by Professor Adam Hedgecoe 
The Counsyl 'Universal Genetic Test' has a distinctly 'retro' feel to it. With its focus on Mendelian disorders (i.e. classic genetic diseases like cystic fibrosis), many of the ethical issues raised by this new service are not new themselves, but rather present new challenges...
25 January 2010 - by Nishat Hyder 
The pioneering genetics research company, deCODE, reemerged last week as a private company with new financial backing. Based in Reykjavik, Iceland, the original company deCODE Genetics, Inc led the way internationally in genetic testing and diagnostics for over a decade. With unique access to genetic information from Iceland's isolated population, the biotech firm has made important discoveries, such as identifying gene variants associated with common conditions ...
30 November 2009 - by Dr Marianne Kennedy 
Postmortem genetic testing of people who have suffered sudden unexplained death (SUD) is a more effective and cost-efficient means of identifying genetic abnormalities that place surviving relatives at risk of fatal heart rhythm disturbances, a new study presented at the American Heart Association's annual meeting in Orlando, US, suggests....
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.